@ShiftRWA See more details: 👇https://t.co/KnWZxKVUFF ...

ZK Rollup Transition - Mantle Network 完成主网升级，采用 OP Succinct 技术 [1] - Mantle Network 成为 TVL 最大的 ZK Rollup，锁定超过 20 亿美元 [1] - 此次升级最终完成 ZK Rollup 的过渡 [1] Ecosystem Development - Mantle Network 为支持 DeFi、RWA 和机构采用的“流动性链”生态系统奠定基础 [1]

RT Andy (@ayyyeandy)Going live with @0xMarcB of @0xPolygon for the kick-off episode of Money Moves Fast.Our premiere show about RWAs, payments, and tokenization...lets go! ...

Major Events - Health 160 (02656) received a subscription rate of 751.77 times for its public offering in Hong Kong, with listing scheduled for September 17 [1] - Huajian Medical (01931) and Renhe International have reached a significant strategic cooperation to establish the world's first vertical RWA exchange focused on the OTC sector [1] - Giant Legend (06683) strategically invested in the operation company of the Bird's Nest to enhance IP and landmark synergy [1] - Yuexiu Property (00123) successfully acquired the Kangqiao land in Hangzhou's Gongshu District for 1.33 billion [1] - China Jinmao (00817) plans to increase capital by 350 million to Beijing Chaoyang and 2.15 billion to Beijing Manmao [1] - Sichuan Energy Investment Development (01713) signed a construction contract with Degge Gesaer Power for development [1] - Qianxun Technology (01640) signed a memorandum of understanding for the proposed acquisition of 100% equity in Punk Code Technology [1] - GCL-Poly Energy (03800) clarified that the profit statement for August-September is not an annual forecast, but based on the trend of polysilicon prices and disclosed data [1] Operating Performance - China Shenhua (01088) reported a coal production of 28.6 million tons in August, a year-on-year decrease of 0.3% [1] - Nanshun (Hong Kong) (00411) announced annual results with a net profit of 303 million HKD, representing a year-on-year increase of 51% [1]

Core Viewpoint - The announcement by Huajian Medical (01931.HK) regarding the establishment of joint ventures and a rebranding signifies a strategic shift towards "on-chain finance," aiming to build the next generation of global asset circulation infrastructure [1][3]. Group 1: Strategic Shift - The name change from "IVD Medical Holding Limited" to "ETHK Labs Inc." reflects a new strategic vision that aligns with its role as a key technology and infrastructure provider in the "ETHK on-chain financial ecosystem" [1][3]. - The establishment of joint ventures alongside the rebranding indicates a systematic increase in investment in digital industries and on-chain finance, suggesting a long-term commitment rather than short-term market speculation [3]. Group 2: Trust Mechanism - There are two contrasting perspectives on Huajian Medical's transformation: supporters believe blockchain can effectively address global asset liquidity issues, while skeptics question the scalability of RWA (Real World Asset) and the clarity of the business model [4][6]. - The ability to build a sustainable, regulatory-compliant, and scalable trust system is crucial for the success of Huajian Medical's strategy [6]. Group 3: Strategic Drivers - The transformation is driven by three factors: the need to overcome growth bottlenecks in existing business, the necessity to attract investor attention with a new global and tech-oriented narrative, and the supportive policy environment in Hong Kong for Web3 and digital asset innovation [8]. Group 4: Value Distribution - Huajian Medical's ETHK ecosystem aims to create new opportunities for asset owners by providing pathways for financing and global market access through on-chain tools [9]. - For capital providers, Huajian Medical is expected to offer new investment interfaces that connect them to high-quality assets traditionally overlooked by the financial system [9]. Group 5: Conclusion - The establishment of joint ventures and the rebranding highlight a significant trend where Chinese quality assets are attempting to achieve global circulation through blockchain technology, while global capital seeks new value anchors [11]. - The success of Huajian Medical in converting its narrative of "on-chain finance" into a credible, investable, and sustainable reality will depend on its ability to address technical implementation, compliance, business models, and ecosystem collaboration [11][12].

Core Viewpoint - Huajian Medical (01931) has announced a strategic partnership with Renhe Pharmaceutical (000650.SZ) to establish the world's first vertical RWA exchange focused on the OTC sector in the United States, marking a significant step in the implementation of its "ETHK blockchain financial ecosystem strategy" [1][2] Group 1: Strategic Collaboration - The collaboration with Renhe Pharmaceutical signifies a new phase in the large-scale implementation and value realization of the "ETHK" blockchain financial ecosystem strategy [1] - This partnership serves as a benchmark case for the innovative "ETHK global RWA exchange" business model, aiming to create a replicable model that validates the feasibility and potential of this innovation [1] Group 2: Vision and Mission - The company believes that the ultimate mission of financial technology is to serve the real economy and create inclusive value, which this collaboration exemplifies [2] - The goal is to empower classic national brands like Renhe Pharmaceutical to achieve digital transformation and promote successful ecological models across various industries, contributing to national industrial upgrades and the development of the digital economy [2] Group 3: Future Outlook - The board is confident that this strong alliance will generate significant synergies, positively impacting the strategic transformation and value reassessment of both companies [2] - The company aims to ensure the successful launch and stable operation of the world's first OTC RWA exchange through close collaboration with Renhe Pharmaceutical, leveraging both parties' resources [2]

Core Viewpoint - The strategic partnership between Huajian Medical and Renhe Pharmaceutical aims to establish the world's first vertical RWA exchange focused on the OTC sector in the United States, marking a significant step in Huajian's ETHK blockchain financial ecosystem strategy [1][2] Group 1: Strategic Collaboration - The collaboration with Renhe Pharmaceutical represents a key milestone in the implementation of Huajian's ETHK blockchain financial ecosystem strategy and the innovative "ETHK global RWA exchange" business model [1] - This partnership is intended to create a replicable model that validates the feasibility and potential of the innovative approach [1] Group 2: Commitment to Economic Development - Huajian Medical emphasizes that the ultimate mission of financial technology is to serve the real economy and create inclusive value, which this collaboration exemplifies [2] - The company aims to leverage technology to assist classic national brands like Renhe Pharmaceutical in their digital transformation, promoting successful ecological models across various industries [2] Group 3: Future Growth and Synergy - The board believes that this collaboration will generate significant synergies, positively impacting the strategic transformation and value reassessment of both companies [2] - Huajian Medical plans to work closely with Renhe Pharmaceutical to ensure the successful launch and stable operation of the world's first OTC RWA exchange, aiming for high standards and quality [2]

Core Viewpoint - The strategic partnership between Huajian Medical and Renhe Pharmaceutical aims to establish the world's first specialized trading platform for over-the-counter (OTC) real-world assets (RWA), addressing a significant gap in the global market [1][2]. Group 1: Strategic Collaboration - The collaboration signifies a new phase in Huajian Medical's "ETHK" blockchain financial ecosystem strategy, marking the global debut of its innovative "ETHK Global RWA Exchange" business model [2]. - Renhe Pharmaceutical, as the president unit of the China OTC Association, plays a crucial role in industry policy discussions and standard-setting, leveraging its strong market position to lead the development of the OTC sector [1][2]. Group 2: Goals and Vision - The partnership reflects the commitment to create a transparent, efficient, and compliant digital trading platform for intangible assets and product rights in the OTC industry, ultimately serving the broader goal of enhancing the digital economy and national industrial upgrades [2]. - The collaboration is expected to generate significant synergies, driving strategic transformation and value reassessment for both companies, while ensuring the successful launch and operation of the OTC RWA exchange [3].

🚀 Avantis $AVNT is one of the hottest names in DeFi right nowWe’ve seen what $MYX did with a 25,000%+ run in just months… and $AVNT is shaping up with the same energy 👀📊 Chart breakout zone: $1.30–$2.00 short-term target, with mid-cycle potential higher if RWA demand explodes.The RWA + derivatives narrative is only just beginning and $AVNT is positioning itself right at the center of it. 🌍📈#AVNT #DeFi #Crypto #Altseason ...

RT Sei (@SeiNetwork)Private credit is the leading RWA sector, representing over 50% of all tokenized value.This market, from corporate loans to HELOCs, has taken off because it’s largely uncorrelated to public markets and offers attractive premiums — now made liquid and composable through tokenization.Private credit demonstrates how tokenization transforms finance — and why every asset class will inevitably move onchain. That trajectory demands performant, institutional-grade rails like Sei.Everything Moves ...